Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | -5.28% | -1.96% | -35.82% |
06-05 | Transcript : Syros Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
05-14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.82% | 142M | |
+53.51% | 59.28B | |
+41.42% | 40.94B | |
-5.42% | 40.17B | |
-5.16% | 28.69B | |
+12.65% | 26.63B | |
-20.94% | 18.89B | |
+30.84% | 12.46B | |
+0.19% | 12.42B | |
+26.21% | 12.26B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Syros Pharmaceuticals : Names Jason Haas CFO